Finance Inquirer
No Result
View All Result
Tuesday, May 13, 2025
  • Login
  • Home
  • Business
  • Technology
  • Finance
  • Stock Market
Subscribe
Finance Inquirer
  • Home
  • Business
  • Technology
  • Finance
  • Stock Market
No Result
View All Result
Finance Inquirer
No Result
View All Result
Home Stock Market

Stock Market Higher After Jobs Report; Health Care Dominates, Led By Humana And Moderna

Tom Hagler by Tom Hagler
10.07.2022
in Stock Market
Stock Market Higher After Jobs Report; Health Care Dominates, Led By Humana And Moderna
152
SHARES
1.9k
VIEWS
Share on FacebookShare on Twitter

After seesaw trading, the stock market traded slightly higher Friday afternoon after the monthly employment report showed stronger-than-expected job growth in June. Health care stocks led, with managed-care provider Humana (HUM), vaccine maker Moderna (MRNA) and Leaderboard stock UnitedHealth Group (UNH) among the top gainers.

X

The Nasdaq inched higher 0.3%, the S&P 500 rose 0.2% and the Dow Jones Industrial Average added 0.3%. The small-cap Russell 2000 rose 0.1%.

Volume rose on the Nasdaq and fell on the NYSE compared with the same time on Thursday.

Most of the S&P sectors traded down or flat, with the exception of health care. The Health Care Select Sector SPDR (XLV) climbed 0.6%.

U.S. Stock Market Today Overview

Index Symbol Price Gain/Loss % Change
Dow Jones (0DJIA) 31462.76 +78.21 +0.25
S&P 500 (0S&P5) 3911.54 +8.92 +0.23
Nasdaq (0NDQC ) 11652.73 +31.38 +0.27
Russell 2000 (IWM) 175.85 +0.24 +0.14
IBD 50 (FFTY) 27.29 +0.04 +0.15
Last Update: 2:54 PM ET 7/8/2022

The economy created 372,000 jobs last month, much higher than the Econoday consensus of 270,000. The unemployment rate stayed at 3.6% for the fourth straight month. Average hourly earnings rose 0.3% from May, in line with estimates. Year over year, wages increased 5.1%, slightly ahead of the 5% consensus.

Stock Market Waits For Signs Of Inflation

“The employment report for June came in much stronger than expected with nonfarm payroll additions well above consensus,” said Charlie Ripley, Senior Investment Strategist at Allianz Investment Management. “While many participants were looking for a broader slowdown in hiring last month, the reality is the demand for labor remains strong and absent a meaningful decline in hiring, it is hard to envision the economy is on the brink of recession. Overall, today’s report simply means the Fed still has more work to do with regards to policy rates to cool demand in the economy and a 75 basis point rate hike is almost a certainty at this point.”

The yield on the 10-year Treasury note climbed 9 basis points to 3.09%.

The price of U.S. crude oil rose 2% to $105 a barrel.

The Innovator IBD 50 ETF (FFTY) rose 0.2%.

Next week kicks off earnings season, with big banks including JPMorgan Chase (JPM) and Morgan Stanley (MS) announcing on Thursday.

Most Trusted Financial Companies – Take A Survey And Win A $50 Amazon Gift Card

Enphase Energy (ENPH) led the S&P 500, up more than 5%. Enphase is prone to volatile price swings, but it’s in position for another breakout try over a 217.33 alternate entry.

Tesla (TSLA) jumped above its 50-day line, helped by news that the company sold 78,906 China-made vehicles in June, up 145% from May.

Health Care Gains

UnitedHealth joined Leaderboard on June 27 when it topped the 500 level. The health insurer cleared a cup-with-handle base today, rising 1.5%. It’s still in the 5% buy zone from the 518.30 entry, but earnings are due late next week.

Covid vaccine stocks Novavax (NVAX) and Moderna (MRNA) surged to three-month highs Friday on growing enthusiasm for an omicron booster campaign in the fall. The Food and Drug Administration recently asked vaccine makers to tailor their next boosters for the new dominant sub-variants, dubbed B.A.4 and B.A.5. Both are offshoots of the omicron strain.

Centene (CNC), a managed health care company, is up more than 3% and breaking out of a double-bottom base on the MarketSmith chart. The stock hit the 87.44 buy point and is in the 5% buy zone to 91.81.

Humana (HUM) remains in the buy range from a buy point of 475.54, although 469.44 was an earlier, viable entry.

Follow Michael Molinski on Twitter @IMmolinski

YOU MAY ALSO LIKE:

Time To Tweak Your Investments To An Inflationary Environment?

Get Full Access To IBD Stock Lists And Ratings

Is XOM A Buy Now After Q1 Earnings?

Get Free IBD Newsletters: Market Prep | Tech Report | How To Invest

What Is CAN SLIM? If You Want To Find Winning Stocks, Better Know It

 

The post Stock Market Higher After Jobs Report; Health Care Dominates, Led By Humana And Moderna appeared first on Investor’s Business Daily.

  • Trending
  • Comments
  • Latest
P2Pro: profitable changes are coming!

P2Pro: profitable changes are coming!

13.09.2022
Saving and investing the two keys to your future retirement

Saving and investing the two keys to your future retirement

21.06.2022
The Dow Jones slept through the whole trade despite positive data from the labor market. Nasdaq had its best streak of gains this year

The Dow Jones slept through the whole trade despite positive data from the labor market. Nasdaq had its best streak of gains this year

01.09.2022
The ranking of countries in terms of the coverage of children with preschool education has been compiled

The ranking of countries in terms of the coverage of children with preschool education has been compiled

03.11.2022
Take the best photos of your life with the new vivo Y76 5G now available

Take the best photos of your life with the new vivo Y76 5G now available

Complete your Christmas shopping with up to 75% off on devices at vivo’s Big Christmas Sale on Shopee

Complete your Christmas shopping with up to 75% off on devices at vivo’s Big Christmas Sale on Shopee

AirPods 3 vs AirPods 2 – What’s the Difference?

AirPods 3 vs AirPods 2 – What’s the Difference?

Want to be a content creator? Here are 5 valuable tips from today’s top Pinoy online celebrities

Want to be a content creator? Here are 5 valuable tips from today’s top Pinoy online celebrities

US Event: Pharma Partnering US Summit 2025

Pharma Partnering EU Summit 2025 Heads to Brussels This May

13.05.2025
US Event: Pharma Partnering US Summit 2025

US Event: Pharma Partnering US Summit 2025

09.05.2025
Knocknock Launches Mobile App for Realtors and Unveils Global Platform Ambitions

Knocknock Launches Mobile App for Realtors and Unveils Global Platform Ambitions

25.04.2025
Biomedical Library offers 24-h Document Delivery Services

Biomedical Library offers 24-h Document Delivery Services

15.04.2025

Recent News

US Event: Pharma Partnering US Summit 2025

Pharma Partnering EU Summit 2025 Heads to Brussels This May

13.05.2025
US Event: Pharma Partnering US Summit 2025

US Event: Pharma Partnering US Summit 2025

09.05.2025

Categories

  • Business
  • Finance
  • News
  • Stock Market
  • Technology
  • Без рубрики

Site Navigation

  • Home
  • Contact Us
Finance Inquirer

We offer multimedia features, easy channel navigation, strong social media presence and numerous engagement platforms that allow the readers to experience content anytime, anywhere, always.

No Result
View All Result
  • Home
  • Business
  • Technology
  • Finance
  • Stock Market

© 2021 financeinquirer.com

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In